Nephrologie et Therapeutique
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 0.8 | Q4 | 14.2% | 0.267 | Q3 | 39.3% |
| 2024 | 0.7 | Q4 | 17.2% | 0.252 | Q3 | 39.6% |
| 2023 | 0.7 | Q4 | 14.3% | 0.193 | Q3 | 33.9% |
| 2022 | 0.7 | Q4 | 15.2% | 0.205 | Q4 | 38.2% |
| 2021 | 0.5 | Q4 | 30.3% | 0.250 | Q3 | 46.0% |
| 2020 | — | — | 0.267 | Q3 | 46.5% | |
| 2019 | — | — | 0.269 | Q3 | 48.7% | |
| 2018 | — | — | 0.276 | Q3 | 47.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1872-9177
ISSN
1769-7255
country
FRcoverage
2005-2026